10-K
Annual Report
OAKTREE ACQUISITION CORP. III LIFE SCIENCES OACC OACCU OACCW
0001193125-26-126536
- Filed
- Mar 26, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Operating Cash Flow | FY 2025 · Dec 31, 2025 | −$422.08K |
| Operating Cash Flow | FY 2025 · Dec 31, 2024 | −$89.69K |
| Cash And Equivalents | FY 2025 · Dec 31, 2025 | $1.43M |
| Cash And Equivalents | FY 2025 · Dec 31, 2024 | $1.36M |
| Stockholders Equity | FY 2025 · Dec 31, 2025 | −$6.77M |
| Stockholders Equity | FY 2025 · Dec 31, 2024 | −$6.07M |
| Stockholders Equity | FY 2025 · Jun 27, 2024 | $0 |
| Current Liabilities | FY 2025 · Dec 31, 2025 | $1.3M |
| Current Liabilities | FY 2025 · Dec 31, 2024 | $727.32K |
| Total Liabilities | FY 2025 · Dec 31, 2025 | $8.32M |
| Total Liabilities | FY 2025 · Dec 31, 2024 | $7.75M |
| Current Assets | FY 2025 · Dec 31, 2025 | $1.55M |
| Current Assets | FY 2025 · Dec 31, 2024 | $1.56M |
| Total Assets | FY 2025 · Dec 31, 2025 | $203.11M |
| Total Assets | FY 2025 · Dec 31, 2024 | $195.25M |
| Net Income | FY 2025 · Dec 31, 2025 | $7.29M |
| Net Income | FY 2025 · Dec 31, 2024 | $1.33M |
| Operating Income | FY 2025 · Dec 31, 2025 | −$1.2M |
| Operating Income | FY 2025 · Dec 31, 2024 | −$351.81K |